ALKYNE-PEG9-BR
中文名稱(chēng) | ALKYNE-PEG9-BR |
---|---|
中文同義詞 | 丙炔-九聚乙二醇-溴;炔-九聚乙二醇-溴;丙炔基-PEG9-溴;炔丙基PEG9-溴化物;炔丙基-九聚乙二醇-溴 |
英文名稱(chēng) | Propargyl-PEG9-bromide |
英文同義詞 | Propargyl-PEG9-bromide;Alkyne-PEG9-Br;Propargyl-PEG9-Br;3,6,9,12,15,18,21,24,27-Nonaoxatriacont-29-yne, 1-bromo-;Propargyl-PEG9-Br/3,6,9,12,15,18,21,24,27-Nonaoxatriacont-29-yne, 1-bromo- |
CAS號(hào) | 2055042-83-4 |
分子式 | C21H39BrO9 |
分子量 | 515.43 |
EINECS號(hào) | |
相關(guān)類(lèi)別 | 助劑 |
Mol文件 | 2055042-83-4.mol |
結(jié)構(gòu)式 |
ALKYNE-PEG9-BR 性質(zhì)
沸點(diǎn) | 525.6±45.0 °C(Predicted) |
---|---|
密度 | 1.200±0.06 g/cm3(Predicted) |
Non-cleavable
|
PEGs
|
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.